Issue of Options
July 16 2003 - 3:34AM
UK Regulatory
RNS Number:6022N
Virotec International Ld
16 July 2003
16 July 2003
ISSUE OF OPTIONS
Virotec International Ltd (ASX/AIM: VTI) advises that it has issued 600,000
options exercisable at A$0.21 each on or before 31 October 2005 pursuant to its
Option Incentive Scheme to employees of the company.
The current issued capital of Virotec is as follows:
168,193,841 Ordinary shares
7,600,000 Options (unquoted) with various expiry dates between 31 August
2003 and 31 March 2006 and exercisable at various exercise prices between A$0.21
and A$1.00.
Bruno Bamonte
Director
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as
available. Information and documents given to ASX become ASX's property and may
be made public.
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/
2001, 11/3/2002, 1/1/2003.
Name of entity
Virotec International Ltd
ABN
81 004 801 398
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough
space).
1 +Class of +securities issued or to be Options
issued
2 Number of +securities issued or to be 600,000
issued (if known) or maximum number
which may be issued
3 Principal terms of the +securities (eg, Options expiring 31 October, 2005 and exercisable at 21
if options, exercise price and expiry cents each issued pursuant to the Virotec Option
date; if partly paid +securities, the Incentive Scheme.
amount outstanding and due dates for
payment; if +convertible securities,
the conversion price and dates for
conversion)
4 Do the +securities rank equally in all Any ordinary shares issued on exercise of
respects from the date of allotment the options will rankequally with existing
with an existing +class of quoted ordinary shares.
+securities?
If the additional securities do not
rank equally, please state:
* the date from which they do
* the extent to which they
participate for the next dividend, (in
the case of a trust, distribution) or
interest payment
* the extent to which they do
not rank equally, other than in
relation to the next dividend,
distribution or interest payment
5 Issue price or consideration Nil
Purpose of the issue Part of Employee Option Incentive Plan
6 (If issued as consideration for the
acquisition of assets, clearly
identify those assets)
7 Dates of entering +securities into 11 July 2003
uncertificated holdings or despatch
of certificates
Number +Class
8 Number and +class of all 168,193,841 Ordinary Shares
+securities quoted on ASX
(including the securities in clause
2 if applicable)
Number +Class
9 Number and +class of all +securities 2,700,000 $1.00 by 31/08/03
not quoted on ASX (including the
securities in clause 2 if applicable) 900,000 $1.00 by 30/11/03
700,000 $0.56 by 30/11/03
200,000 $0.47 by 28/02/04
150,000 $0.47 by 30/7/05
1,100,000 $1.00 by 30/7/05
400,000 $0.61 by 31/10/05
100,000 $0.30 by 31/3/05
750,000 $0.50 by 31/03/06
600,000 $0.21 by 31/10/05
10 Dividend policy (in the case of a N/A
trust, distribution policy) on the
increased capital (interests)
Part 2 - Bonus issue or pro rata issue - N/A
11 Is security holder approval required?
12 Is the issue renounceable or
non-renounceable?
13 Ratio in which the +securities will be
offered
14 +Class of +securities to which the
offer relates
15 +Record date to determine entitlements
16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17 Policy for deciding entitlements in
relation to fractions
18 Names of countries in which the entity
has +security holders who will not be
sent new issue documents
Note: Security holders must be told how
their entitlements are to be dealt
with.
Cross reference: rule 7.7.
19 Closing date for receipt of acceptances
or renunciations
20 Names of any underwriters
21 Amount of any underwriting fee or
commission
22 Names of any brokers to the issue
23 Fee or commission payable to the
broker to the issue
24 Amount of any handling fee payable to
brokers who lodge acceptances or
renunciations on behalf of +security
holders
25 If the issue is contingent on +security
holders' approval, the date of the
meeting
26 Date entitlement and acceptance form
and prospectus or Product Disclosure
Statement will be sent to persons
entitled
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do +security holders sell their
entitlements in full through a broker?
31 How do +security holders sell part of
their entitlements through a broker and
accept for the balance?
32 How do +security holders dispose of
their entitlements (except by sale
through a broker)?
33 +Despatch date
Part 3 - Quotation of securities - N/A
You need only complete this section if you are applying for quotation of
securities
34 Type of securities
(tick one)
(a) FORMCHECKBOX Securities described in Part 1
(b) FORMCHECKBOX All other securities
Example: restricted securities at the end of the escrowed period, partly paid securities
that become fully paid, employee incentive share securities when restriction ends,
securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information
or documents
35 FORMCHECKBOX If the +securities are +equity securities, the names of the 20 largest holders of the
additional +securities, and the number and percentage of additional +securities held by
those holders
36 FORMCHECKBOX If the +securities are +equity securities, a distribution schedule of the additional
+securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 FORMCHECKBOX A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of securities for which
+quotation is sought
39 Class of +securities for which
quotation is sought
40 Do the +securities rank equally in all
respects from the date of allotment
with an existing +class of quoted
+securities?
If the additional securities do not
rank equally, please state:
* the date from which they do
* the extent to which they
participate for the next dividend, (in
the case of a trust, distribution) or
interest payment
* the extent to which they do not
rank equally, other than in relation to
the next dividend, distribution or
interest payment
41 Reason for request for quotation now
Example: In the case of restricted
securities, end of restriction period
(if issued upon conversion of another
security, clearly identify that other
security)
Number +Class
42 Number and +class of all +securities
quoted on ASX (including the securities
in clause 38)
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute
discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
* The issue of the +securities to be quoted complies with the law and
is not for an illegal purpose.
* There is no reason why those +securities should not be granted
+quotation.
* An offer of the +securities for sale within 12 months after their
issue will not require disclosure under section 707(3) or section 1012C(6) of
the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for
the securities in order to be able to give this warranty
* Section 724 or section 1016E of the Corporations Act does not apply
to any applications received by us in relation to any +securities to be quoted
and that no-one has any right to return any +securities to be quoted under
sections 737, 738 or 1016F of the Corporations Act at the time that we request
that the +securities be quoted.
* We warrant that if confirmation is required under section 1017F of
the Corporations Act in relation to the +securities to be quoted, it has been
provided at the time that we request that the +securities be quoted.
* If we are a trust, we warrant that no person has the right to return
the +securities to be quoted under section 1019B of the Corporations Act at the
time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in
respect of any claim, action or expense arising from or connected with any
breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If
any information or document not available now, will give it to ASX before
+quotation of the +securities begins. We acknowledge that ASX is relying on the
information and documents. We warrant that they are (will be) true and
complete.
Sign here: ............................................................
Date: .16 July 2003..
(Director)
Print name: ..BRUNO BAMONTE.......................................................
== == == == ==
VIROTEC INTERNATIONAL LTD
ABN 81 004 801 398
PO BOX 188
SANCTUARY COVE QLD 4212
AUSTRALIA
www.virotec.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUNOBRORRBARR